Vedanta Biosciences to collaborate on cancer therapies with NYU Langone
16 August 2016 | By Niamh Louise Marriott, Digital Content Producer
The drug development company will collaborate with the research centre on develoing microbiome-derived immunotherapies for cancer patients, to influence the efficacy of checkpoint inhibitors...